Hydromer Expands European Medical Coating Access Through Avem Partnership

Hydromer, Inc. has announced a new commercial partnership with Avem Market Solutions that significantly strengthens the company's reach and technical support capabilities for medical device developers throughout Europe and the United Kingdom. This collaboration creates a more accessible path for European device manufacturers who require advanced surface solutions by leveraging Avem's expertise in connecting Medtech OEMs and CDMOs with specialized suppliers for contract design and manufacturing services.

As Hydromer's strategic representative in the region, Avem will provide direct access to hydrophilic, lubricious, antimicrobial, and thrombo-resistant coating platforms along with custom formulation and R&D support for early development. The partnership also offers scalable coating equipment and tailored system design, complemented by localized commercial guidance from a team immersed in the EU and UK medtech ecosystems. The unified approach aims to help developers reduce time to market, enhance device performance, and streamline the transition from prototype to full-scale manufacturing.

This partnership addresses the increasing pressure European and UK medtech companies face to innovate quickly while meeting strict regulatory expectations. By combining Hydromer's deep scientific expertise with Avem's regional commercial insight, the collaboration makes advanced coating solutions easier to access, understand, and implement. Device manufacturers gain earlier visibility into validated coating options, hands-on support for feasibility studies and scale-up, and a reliable resource for navigating technical and operational challenges.

The partnership provides a direct channel to explore coating technologies proven in global markets through established distribution networks. For decades, Hydromer's coatings have been integrated into devices used in interventional, surgical, and diagnostic procedures worldwide. This strategic alliance is designed to eliminate barriers and empower innovators at every stage of product development, from initial concept through commercialization and market expansion across European territories.